# ZYMFENTRA
> **BLA761358** · Biologics License Application · Sponsor: CELLTRION · Approved 2023-10-20
## Drug
- **FDA Application Number:** BLA761358
- **Application type:** Biologics License Application
- **Brand name:** ZYMFENTRA
- **Generic name:** INFLIXIMAB-DYYB
- **Active ingredients:** INFLIXIMAB-DYYB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CELLTRION
- **Manufacturer:** CELLTRION USA Inc.
- **First approval:** 2023-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761358)
---
*MORVS · CC0 1.0*